Novo Nordisk to enter RNA market with Dicerna purchaseDenmark's Novo Nordisk, the world's leading insulin maker, has revealed it will buy US-based Dicerna Pharmaceuticals, a developer of RNA...
FDA approves Novo Nordisk’s Wegovy (semaglutide 2.4 mg) for weight managementThe FDA has approved Novo Nordisk’s Wegovy (the brand name for once-weekly semaglutide 2.4mg injection in the US) for chronic weight...